Aurobindo Pharma among 8 BSE Pharma Index stocks which surge to new 52-week highs on Friday

The pharmaceutical sector witnessed a wave of achievements on July 21, 2023, as several leading stocks from the S&P BSE Pharma Index surged to new 52-week highs. The data was sourced from BSE at 2.40 pm, and the updates from the real-time data could come with a lag. The below data also pertains only to the time at which it was taken.

1. Aurobindo Pharma
Aurobindo Pharma soared to a new 52-week high at Rs. 791.5 on July 21, 2023.

2. Glenmark Life Sciences
Glenmark Life Sciences achieved a new 52-week high at Rs. 658 on July 21, 2023. As a subsidiary of Glenmark Pharma, Glenmark Life Sciences is a leading developer and manufacturer of active pharmaceutical ingredients (APIs) and intermediates.

3. Rainbow Children's Medicare
Rainbow Children's Medicare touched a new 52-week high at Rs. 1,139 on July 21, 2023.

4. Neuland Laboratories
Neuland Laboratories surged to a new 52-week high at Rs. 3,389.65 on July 21, 2023.

5. Glenmark Pharma
Glenmark Pharma reached a new 52-week high at Rs. 755 on July 21, 2023.

6. Lupin
Lupin touched a new 52-week high at Rs. 947.95 on July 21, 2023.

7. Sun Pharma
Sun Pharma surged to a new 52-week high at Rs. 1,107.95 on July 21, 2023.

8. Torrent Pharmaceuticals
Torrent Pharmaceuticals achieved a new 52-week high at Rs. 1,982.55 on July 21, 2023.

(Disclaimer: This is an AI-generated article. Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)